HGHaley Graver

Haley Graver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haley Graver has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Treatment Utilization, Help‐Seeking, and Illness Experiences Among Mandarin‐Speaking Asian Americans With Eating Disorders: A Cross‐Sectional Study

    by Haley Graver, Boaz L. Yang, Lanye Wang, Laura M. Thornton, Cynthia M. Bulik, Ya‐Ke Wu

    Objective: Despite comparable or higher eating disorders (EDs) rates, Asian Americans are less likely to seek treatment than non‐Hispanic White individuals. This study examined treatment utilization, help‐seeking behaviors, and self‐reported factors related to illness development, impact, and recovery among Mandarin‐speaking Asian Americans with current or past EDs and explored sex differences. Method: A cross‐sectional study was conducted among 196 Mandarin‐speaking Asian Americans with current or past EDs. Participants completed self‐report measures assessing ED diagnoses determined by algorithm, treatment utilization, help‐seeking behaviors, perceived contributors to ED development, illness impact, and recovery factors. Descriptive statistics were calculated, and sex differences were examined using Mann–Whitney U tests and Fisher's exact tests. Results: Most participants (76.5%) reported never receiving treatment for their ED . Among those who had received treatment, many (60.5%) delayed seeking help for 6 months or longer. Psychiatrists were the most common initial diagnosing providers, and outpatient care was the most common treatment setting. Treatment utilization did not differ significantly by sex. Female participants reported greater contributions of weight‐ or appearance‐related bullying/teasing to ED development, greater impacts on social and parental relationships, and greater importance of educational or occupational changes in recovery compared with male participants. Discussion: Findings highlight substantial gaps in ED treatment utilization and help‐seeking among Mandarin‐speaking Asian Americans. Although treatment utilization was similar across sexes, differences in illness contributors, impacts, and recovery priorities suggest sex‐specific ED experiences. Culturally and linguistically appropriate outreach, screening, and treatment approaches are needed to better support recovery among Asian Americans with EDs .

  • A Multi‐Site Study of Brief Cognitive‐Behavioural Therapy for Eating Disorders for Individuals With BMI ≥ 30

    by Ashley Dunford, P. Evelyna Kambanis, Lilian P. Palmer, Haley Graver, Megan E. Liu, Jordan Hillard, Stefania Yee, Hannah Turner, Lauren Breithaupt, Emma Evans, et al.

    Objective: Cognitive‐behavioural therapy (CBT) for eating disorders (EDs) has raised concerns of appropriateness for patients in higher‐weight bodies. We evaluated acceptability (Sample 1—United States [USA]) and effectiveness (Sample 1—USA, Sample 2—United Kingdom [UK]) of CBT‐T by body mass index [BMI] category. We hypothesised that individuals with BMI ≥ 30 kg/m 2 would be more likely to drop out and show smaller symptom reductions compared to participants with BMI < 30 kg/m 2 . Methods: Participants with non‐underweight EDs (USA: n = 63; UK: n = 58) received CBT‐T and completed the ED‐15 to evaluate change in behaviours (objective binge eating, purging, restriction, excessive exercise) and cognitions (Eating Concern, Weight/Shape Concern, Global Score). Results: Contrary to hypotheses, CBT‐T completion did not differ by BMI category. Participants demonstrated large and significant reductions in binge eating, excessive exercise, and ED cognitions, with no significant differences by BMI (USA, UK). Although the BMI ≥ 30 kg/m 2 group demonstrated significantly smaller reductions in restriction and purging (UK only), smaller reductions in the higher‐weight group were fully explained by their significantly lower pre‐treatment symptoms. Discussion: Results from this exploratory multisite study found no evidence that CBT‐T was less acceptable or effective for participants in higher‐weight bodies.


  • An Exploratory Study of Neural Response to Food Cues Following Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder

    by Kendra R. Becker, Haley Graver, Avery L. Van De Water, Abigail G. Dalton, Rebecca Karlson, Lilian P. Palmer, Casey Stern, Lauren Breithaupt, Helen Burton‐Murray, Megan Kuhnle, et al.

    Objective: Avoidant/restrictive food intake disorder (ARFID) is characterized by limited dietary volume and/or variety due to fear of aversive consequences, lack of interest in eating, and/or sensory sensitivity. Uncontrolled studies suggest that cognitive‐behavioral therapy for ARFID (CBT‐AR) is beneficial, but neural mechanisms remain unknown. Prior work has shown hyperactivation in regions of the salience network (SN) during the presentation of food stimuli in ARFID compared to healthy controls, and the SN shows reduction from pre‐ to post‐CBT in anxiety disorders. We tested hypotheses that (1) higher pre‐treatment food‐related activation in the SN (anterior cingulate cortex [ACC], anterior insula, amygdala) would be prospectively associated with greater reductions in ARFID severity at post‐treatment, and (2) food‐related activation in the SN would decrease from pre‐ to post‐treatment. Method: In a validated functional magnetic resonance imaging (fMRI) food cue paradigm, youth with ARFID viewed images of food and non‐food in a fasted state at pre‐treatment ( N = 24) and a subset ( N = 14) also completed post‐treatment scans. Results: Pre‐treatment activation in response to food versus objects was not associated with changes in ARFID severity or remission post‐treatment. However, hyperactivation in the right ACC (MNI coordinates: 3, 53, 17; k ( E ) = 579, p (FWE corr ) = 0.013) decreased from pre‐ to post‐treatment with a large effect size ( d = 1.1). Conclusion: These pilot findings raise the possibility that changes in SN neural activity may be candidate mechanisms through which CBT‐AR exerts its effects. Randomized controlled trials are needed to replicate and extend these results. Trial Registration: ClinicalTrials.gov identifier: NCT02963220


  • Open Access

    Unique and Shared Symptoms Across Food Addiction and Binge‐Eating Measures: A Content Analysis

    by Haley Graver, Hannah C. McCausland, Macarena Kruger, Laura G. Rubino, Jannah R. Moussaoui, Lindsey Parnarouskis, Erica M. LaFata, Stephanie Manasse

    Objective: We aimed to determine if the high co‐occurrence rates between food addiction (FA) and binge‐spectrum eating disorders (BSEDs) are partially due to their respective measures assessing similar symptoms. Specifically, we aimed to clarify whether the Yale Food Addiction Scale 2.0 (YFAS 2.0) assesses a distinct symptom profile from common BSED measures (e.g., measures of binge‐eating disorder (BED) or bulimia nervosa). Because FA does not include compensatory behaviors, our comparison focused specifically on FA and binge‐related features of BSEDs. Method: We conducted a content analysis on the YFAS 2.0 and five of the most cited BSED measures. Five trained coders inductively assigned symptom codes to every item from each measure. Because FA does not include compensatory behaviors, we removed compensatory‐behavior items from the BSED measures prior to coding to focus on binge‐related content. We then calculated Jaccard similarity coefficients to quantify symptom overlap between measures. Results: The YFAS 2.0 showed very low symptom overlap with the BSED measures (Jaccard range = 0.08–0.19). However, nearly half (47%) of its symptoms were captured by at least one BSED measure. The symptoms assessed by the YFAS 2.0 and not the BSED measures tended to focus on the impairment and consequences of eating behavior, whereas the BSED measures focused more on the cognitive features of eating behavior. Discussion: This comparison revealed both differences and similarities between FA and BSED measures. Although the YFAS 2.0 showed limited overlap with any single BSED measure, about half of its symptoms were represented in at least one BSED measure, indicating partial shared content. The FA and BSED measures also reflect different theoretical emphases, with FA focusing on impairment and BSEDs emphasizing cognitive and behavioral features. Further clarifying how FA and BED relate will require integrating measurement patterns with evidence on mechanisms and clinical course.


  • An exploration of the role of spiritual distress in eating disorder recovery.

    by Haley Graver, Sarah M. Coyne, Lauren A. Barnes, Peter Sanders

  • Open Access

    Ecological momentary interventions for eating disorders: a systematic review of the nascent science and recommendations for future research

    by Macarena Kruger, Jianyi Liu, Haley Graver, Stephanie Manasse, Elizabeth A. Velkoff

    Ecological momentary interventions (EMIs) deliver real-time, technology-based support in everyday settings. They have been used as standalone treatments or adjuncts to traditional care, with growing but still limited evidence supporting their effectiveness. EMIs offer a method for reducing barriers to care such as high costs, stigma, and limited access to providers – issues particularly relevant to eating disorder (ED) treatment, given the expense of inpatient care and the scarcity of specialized providers. This review examines existing research on EMIs for ED treatment, their design and content, and directions for future research. We conducted a systematic review of EMI studies for EDs using PubMed, PsycINFO, Web of Science, and the Cochrane Library. Following screening for eligibility, we extracted data on study population, EMI design, and outcomes. Study quality was assessed using the Effective Public Health Practice Quality Assessment Tool (EPHPP). Our search identified 279 unique studies, of which eight met inclusion criteria. EMI notification content, timing, and delivery method varied across studies. Most studies included self-report or monitoring measures (7/8; 87.5%) to inform momentary delivery of tailored interventions. The effectiveness of EMIs showed mixed results. Of the two randomized-controlled trials included, both investigated EMIs as an adjunct to cognitive-behavioral therapy (CBT) and found that EMIs did not significantly enhance symptom reduction or skill acquisition beyond CBT alone. Studies testing EMI for maintaining treatment gains reported improvement in remission rates and symptom reduction, but poor adherence makes these results difficult to interpret. The average quality rating of the studies included was moderate. Given the limited number of studies, we cannot draw broad conclusions about EMI effectiveness. We identified key gaps to address in future research, including examining moderators and mechanisms of EMI efficacy, refining EMI design to reduce participant burden, leveraging advanced technology for greater personalization of interventions, and recruiting larger and more diverse samples. Addressing these gaps will help clarify EMIs’ potential role in improving ED treatment. Eating disorders are a major and increasing public health concern in the United States. However, it is difficult to access optimal treatment. Some individuals may feel scared or ashamed to seek treatment, whereas others may not be able to afford treatment-related costs. One way to address these problems is with ecological momentary interventions (EMIs), which use technology to provide support to individuals in real-time and in real-world settings, meaning that they do not necessarily need to go to a health care facility to receive care. In this study, we reviewed eight papers about EMIs to treat eating disorders. We found that EMIs have sometimes been used as the unique treatment provided to patients, but mostly as an additional component to regular treatment. In most studies, participants received EMIs through smartphone applications, followed by text messaging and the Internet. Results showed that participants’ eating disorder symptoms generally improved after receiving EMIs. And yet, there were some inconsistent findings, as well as a large variability in the different EMI components that seem to work best. We provide recommendations for future research studies, such as including larger samples of more diverse participants and developing more personalized features according to participants’ needs.


  • Patterns of Symptom Change in Behaviors and Cognitions During 10‐Session Cognitive Behavioral Therapy (CBT‐T) for Non‐Underweight Eating Disorders

    by P. Evelyna Kambanis, Haley Graver, Lilian P. Palmer, Casey M. Stern, Nassim Tabri, Ashley Dunford, Helen Burton‐Murray, Lauren Breithaupt, Shirley B. Wang, Setareh M. Rossman, et al.

    Objective: Little is known about the timing of behavioral versus cognitive change in 10‐session cognitive‐behavioral therapy for non‐underweight eating disorders (CBT‐T). We aimed to: (a) evaluate the magnitude of behavioral and cognitive symptom reduction across treatment; and (b) investigate the relation between early behavioral change and subsequent cognitive change. We hypothesized: (a) large and significant reductions in behavioral and cognitive symptoms from pre‐ to mid‐treatment and from pre‐ to post‐treatment; and (b) that early behavioral change would predict subsequent cognitive change over the course of treatment.Method: Patients (N = 63) were offered CBT‐T and completed the Eating Disorder‐15 on a weekly basis. We used intent‐to‐treat analyses. For Aim 1, we conducted a series of fixed‐effect multilevel models for each outcome variable, accounting for repeated measures (pre‐, mid‐, and post‐treatment) within individuals. For Aim 2, we conducted a linear regression using early behavioral change as the predictor and subsequent cognitive change as the outcome.Results: We observed large and significant reductions in most behavioral and all cognitive symptoms pre‐ to mid‐treatment and pre‐ to post‐treatment. Early changes in behavioral symptoms did not significantly predict subsequent cognitive changes.Discussion: Behavioral improvements occurred rapidly and were sustained throughout treatment, whereas cognitive changes followed a more gradual trajectory. The absence of a significant predictive relationship between early behavioral change and subsequent cognitive change suggests that these domains may improve independently. Future research should investigate the mechanisms linking behavioral and cognitive changes.


  • Frequency and Predictors of Shape/Weight Concerns and Objective Binge Eating in Avoidant/Restrictive Food Intake Disorder (ARFID)

    by P. Evelyna Kambanis, Lilian P. Palmer, Grace Jhe, Iman McPherson, Haley Graver, Abigail G. Dalton, Chunni Ji, Elisa Asanza, Lauren Shabazian, Ashley Dunford, et al.

    Objective: DSM‐5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co‐occur, and DSM‐5‐TR now permits comorbid binge‐eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical‐level shape/weight concerns and past‐month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical‐level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory.Method: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination—Questionnaire (EDE‐Q).Results: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical‐level shape/weight concerns, and 15% reported past‐month OBEs. Higher weight uniquely predicted shape/weight concerns.Discussion: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID—particularly those at higher weights—may experience clinical‐level shape/weight concerns and OBEs.


  • Difficulties in Emotion Regulation in Avoidant/Restrictive Food Intake Disorder

    by Casey M. Stern, Haley Graver, Iman McPherson, Julia Gydus, P. Evelyna Kambanis, Lauren Breithaupt, Helen Burton‐Murray, Lázaro Zayas, Kamryn T. Eddy, Jennifer J. Thomas, et al.

    Objective: Despite substantial research indicating difficulties with emotion regulation across eating disorder presentations, emotion regulation has yet to be studied in adults with avoidant/restrictive food intake disorder (ARFID). We hypothesized that (1) those with ARFID would report greater overall emotion regulation difficulties than nonclinical participants, and (2) those with ARFID would not differ from those with other eating disorders on the level of emotion regulation difficulty.Methods: One hundred and thirty‐seven adults (age 18–30) from an outpatient clinic with ARFID (n = 27), with other primarily restrictive eating disorders (e.g., anorexia nervosa; n = 34), and with binge/purge eating disorders (e.g., bulimia nervosa; n = 51), as well as nonclinical participants (n = 25) recruited via Amazon Mechanical Turk (MTurk) completed the Difficulties in Emotion Regulation Scale (DERS). We compared DERS scores across groups.Results: In line with expectations, patients with ARFID scored significantly higher than nonclinical participants on the DERS Total (p = 0.01) with a large effect size (d = 0.87). Also as hypothesized, those with ARFID did not differ from those with other primarily restrictive (p = 0.99) or binge/purge disorders (p = 0.29) on DERS Total.Discussion: Adults with ARFID appear to exhibit emotion regulation difficulties which are greater than nonclinical participants, and commensurate with other eating disorders. These findings highlight the possibility of emotion regulation difficulties as a maintenance mechanism for ARFID.


  • Open Access

    Avoidant/restrictive food intake disorder differs from anorexia nervosa in delay discounting

    by Casey M. Stern, Iman McPherson, Melissa J. Dreier, Kathryn Coniglio, Lilian P. Palmer, Julia Gydus, Haley Graver, Laura T. Germine, Nassim Tabri, Shirley B. Wang, et al.

    Background: Avoidant/restrictive food intake disorder (ARFID) and anorexia nervosa (AN) are the two primary restrictive eating disorders; however, they are driven by differing motives for inadequate dietary intake. Despite overlap in restrictive eating behaviors and subsequent malnutrition, it remains unknown if ARFID and AN also share commonalities in their cognitive profiles, with cognitive alterations being a key identifier of AN. Discounting the present value of future outcomes with increasing delay to their expected receipt represents a core cognitive process guiding human decision-making. A hallmark cognitive characteristic of individuals with AN (vs. healthy controls [HC]) is reduced discounting of future outcomes, resulting in reduced impulsivity and higher likelihood of favoring delayed gratification. Whether individuals with ARFID display a similar reduction in delay discounting as those with AN (vs. an opposing bias towards increased delay discounting or no bias) is important in informing transdiagnostic versus disorder-specific cognitive characteristics and optimizing future intervention strategies. Method: To address this research question, 104 participants (ARFID: n = 57, AN: n = 28, HC: n = 19) completed a computerized Delay Discounting Task. Groups were compared by their delay discounting parameter (ln)k. Results: Individuals with ARFID displayed a larger delay discounting parameter than those with AN, indicating steeper delay discounting (M ± SD = −6.10 ± 2.00 vs. −7.26 ± 1.73, p = 0.026 [age-adjusted], Hedges’ g = 0.59), with no difference from HC (p = 0.514, Hedges’ g = −0.35). Conclusion: Our findings provide a first indication of distinct cognitive profiles among the two primary restrictive eating disorders. The present results, together with future research spanning additional cognitive domains and including larger and more diverse samples of individuals with ARFID (vs. AN), will contribute to identifying maintenance mechanisms that are unique to each disorder as well as contribute to the optimization and tailoring of treatment strategies across the spectrum of restrictive eating disorders.